Abattis Bioceuticals Corp. Announces Postponement of its Annual General Meeting (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / February 14, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company”) is announcing today that it will be seeking to adjourn its upcoming annual general meeting of shareholders, originally scheduled to be held on Friday, February 17, 2017, at 10:00 a.m. (Vancouver time) (the “Meeting”), to a to-be-announced date. The Company […]